Natural Health Science News The latest news and top resources on natural health.

Diabetes – Weight Loss

Posted January 3, 2012

Nutritional factors and diabetic foot: A role for vitamin E? 1

Rigalleau, V., M. Barbe, F. Garuz, L. Baillet-Blanco, M. C. Beauvieux, and H. Gin. 2004. Nutritional factors and diabetic foot: a role for vitamin E? Diabet Med 21 (8):951-2.

Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities

Fukino, Y., A. Ikeda, K. Maruyama, N. Aoki, T. Okubo, and H. Iso. 2008. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 62 (8):953-60.

Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes.

Martin, J., Z. Q. Wang, X. H. Zhang, D. Wachtel, J. Volaufova, D. E. Matthews, and W. T. Cefalu. 2006. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care 29 (8):1826-32.

Effects of Okchun-San, a herbal formulation, on blood glucose levels and body weight in a model of Type 2 diabetes

Chang, M. S., M. S. Oh, R. Kim do, K. J. Jung, S. Park, S. B. Choi, B. S. Ko, and S. K. Park. 2006. Effects of okchun-san, a herbal formulation, on blood glucose levels and body weight in a model of Type 2 diabetes. J Ethnopharmacol 103 (3):491-5.

Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients

Andersen, T., and J. Fogh. 2001. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. J Hum Nutr Diet 14 (3):243-50.

Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance.

Hioki, C., K. Yoshimoto, and T. Yoshida. 2004. Efficacy of bofu-tsusho-san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clin Exp Pharmacol Physiol 31 (9):614-9.

Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: The Hordaland Health Study

Raeder, M. B., I. Bjelland, S. Emil Vollset, and V. M. Steen. 2006. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the Hordaland Health Study. J Clin Psychiatry 67 (12):1974-82.

Sibutramine: balancing weight loss benefit and possible cardiovascular risk.

de Simone, G., and G. D’Addeo. 2008. Sibutramine: balancing weight loss benefit and possible cardiovascular risk. Nutr Metab Cardiovasc Dis 18 (5):337-41.

Olanzapine-associated type 2 diabetes mellitus.

Opp, D., and C. Hildebrandt. 2002. Olanzapine-associated type 2 diabetes mellitus. Schizophr Res 56 (1-2):195-6.

Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States.

Feldman, P. D., L. K. Hay, W. Deberdt, J. S. Kennedy, D. S. Hutchins, D. P. Hay, T. A. Hardy, V. P. Hoffmann, K. Hornbuckle, and A. Breier. 2004. Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States. J Am Med Dir Assoc 5 (1):38-46.

Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.

Rubin, R. R., Y. Ma, D. G. Marrero, M. Peyrot, E. L. Barrett-Connor, S. E. Kahn, S. M. Haffner, D. W. Price, and W. C. Knowler. 2008. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 31 (3):420-6.

Review of drugs for diabetes and related diseases–side effects, drug interaction and overdosagea

Endo, T. 1991. [Review of drugs for diabetes and related diseases–side effects, drug interaction and overdosage]. Nihon Rinsho 49 Suppl:849-911.

Review of duloxetine in the management of diabetic peripheral neuropathic pain

Smith, T., and R. A. Nicholson. 2007. Review of duloxetine in the management of diabetic peripheral neuropathic pain. Vasc Health Risk Manag 3 (6):833-44.

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: Systematic review of randomised trials

Sultan, A., H. Gaskell, S. Derry, and R. A. Moore. 2008. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol 8:29.

The association between antidepressant use and hypoglycaemia in diabetic patients: A nested case-control study

Derijks, H. J., E. R. Heerdink, F. H. De Koning, R. Janknegt, O. H. Klungel, and A. C. Egberts. 2008. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepidemiol Drug Saf 17 (4):336-44.

Anti-diabetic drug use and the risk of motor vehicle crash in the elderly

Hemmelgarn, B., L. E. Levesque, and S. Suissa. 2006. Anti-diabetic drug use and the risk of motor vehicle crash in the elderly. Can J Clin Pharmacol 13 (1):e112-20.

A puzzling link. Antidepressants and diabetes.

Ruder, K. 2007. A puzzling link. Antidepressants and diabetes. Diabetes Forecast 60 (2):21.

Type of antidepressant therapy and risk of type 2 diabetes in people with depression

Brown, L. C., S. R. Majumdar, and J. A. Johnson. 2008. Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Diabetes Res Clin Pract 79 (1):61-7.

Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus – A meta-analysis

Norris, S. L., X. Zhang, A. Avenell, E. Gregg, C. H. Schmid, C. Kim, and J. Lau. 2004. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 164 (13):1395-404.

New drugs; rimonabant.

van Bronswijk, H., E. A. Dubois, H. Pijl, and A. F. Cohen. 2007. [New drugs; rimonabant]. Ned Tijdschr Geneeskd 151 (47):2620-2.

Pharmacologic induction of weight loss to treat type 2 diabetes

Redmon, J. B., S. K. Raatz, C. A. Kwong, J. E. Swanson, W. Thomas, and J. P. Bantle. 1999. Pharmacologic induction of weight loss to treat type 2 diabetes. Diabetes Care 22 (6):896-903.

Medication cost savings associated with weight loss for obese non-insulin-dependent diabetic men and women.

Collins, R. W., and J. W. Anderson. 1995. Medication cost savings associated with weight loss for obese non-insulin-dependent diabetic men and women. Prev Med 24 (4):369-74.